| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051730726 |
| P356 | DOI | 10.1007/S12035-016-9717-5 |
| P698 | PubMed publication ID | 26801190 |
| P5875 | ResearchGate publication ID | 291553073 |
| P50 | author | Rafael C Dutra | Q82455511 |
| Mauricio P. Cunha | Q41090858 | ||
| Ana Lúcia S Rodrigues | Q41090877 | ||
| Vicente Lieberknecht | Q41630648 | ||
| Adair R Santos | Q58810515 | ||
| Luiz F de Souza | Q59160053 | ||
| P2093 | author name string | Alcir L Dafré | |
| Stella C Junqueira | |||
| Igor S Coelho | |||
| Thaís A Barbosa | |||
| P2860 | cites work | Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis | Q72440128 |
| Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123 | Q78115652 | ||
| Expression profiling identifies a molecular signature of reactive astrocytes stimulated by cyclic AMP or proinflammatory cytokines | Q80135843 | ||
| Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase | Q83790949 | ||
| A D2-like receptor family agonist produces analgesia in mechanonociception but not in thermonociception at the spinal cord level in rats | Q85961921 | ||
| Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse | Q87491257 | ||
| Multiple sclerosis genetics | Q87928799 | ||
| The role of oxidative stress in Parkinson's disease | Q24307946 | ||
| Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution | Q24679240 | ||
| The dopaminergic system in autoimmune diseases | Q27023885 | ||
| Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity | Q28261030 | ||
| A review of the receptor-binding and pharmacokinetic properties of dopamine agonists | Q28264219 | ||
| Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. | Q33304994 | ||
| Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole | Q33529864 | ||
| Treatment of paroxysmal symptoms in multiple sclerosis with bromocriptine | Q33733763 | ||
| Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosis | Q33928228 | ||
| The role of pramipexole in a severe Parkinson's disease model in mice | Q34409425 | ||
| Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity | Q34528753 | ||
| Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. | Q34937637 | ||
| Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels | Q35016996 | ||
| Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis | Q35150296 | ||
| T cell subsets and their signature cytokines in autoimmune and inflammatory diseases | Q35558638 | ||
| Signaling via the kinase p38α programs dendritic cells to drive TH17 differentiation and autoimmune inflammation | Q35685580 | ||
| The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy | Q35688436 | ||
| Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery | Q36610346 | ||
| Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein | Q36653589 | ||
| Astrocytes--friends or foes in multiple sclerosis? | Q36878427 | ||
| Persistent inflammation in the CNS during chronic EAE despite local absence of IL-17 production | Q37010063 | ||
| Evidence for plasticity of the dopaminergic system in parkinsonism | Q37071593 | ||
| Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade | Q37416273 | ||
| Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis | Q37541906 | ||
| Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis | Q37591113 | ||
| Role of dopamine in the physiology of T-cells and dendritic cells | Q37592480 | ||
| Behavioural symptoms and impairments in multiple sclerosis: a systematic review and meta-analysis | Q37989889 | ||
| Alpha-synuclein: from secretion to dysfunction and death | Q38028819 | ||
| Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis | Q38299101 | ||
| Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease | Q38361158 | ||
| Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases | Q38366498 | ||
| A basic overview of multiple sclerosis immunopathology | Q38587668 | ||
| Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease | Q39679553 | ||
| Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions | Q39806585 | ||
| Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice. | Q39818078 | ||
| Cutting edge: the pathogenicity of IFN-γ-producing Th17 cells is independent of T-bet | Q40021485 | ||
| Lipopolysaccharide-induced tumor necrosis factor-alpha release is controlled by the central nervous system | Q42514676 | ||
| α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment. | Q43065145 | ||
| Dopamine D2-like receptor signaling suppresses human osteoclastogenesis | Q43695074 | ||
| Distorted expression of dopamine receptor genes in systemic lupus erythematosus. | Q43794562 | ||
| Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons | Q44258606 | ||
| Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain | Q44590392 | ||
| The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes. | Q46024602 | ||
| Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia | Q46153754 | ||
| Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions. | Q46158259 | ||
| Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis | Q46536902 | ||
| Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta | Q46602974 | ||
| Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice. | Q46667103 | ||
| The effects of diacerhein on mechanical allodynia in inflammatory and neuropathic models of nociception in mice. | Q46814798 | ||
| Comparison of three models of neuropathic pain in mice using a new method to assess cold allodynia: the double plate technique | Q46953891 | ||
| In vitro activation of mouse neutrophils by recombinant human interferon-gamma: increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines | Q46955583 | ||
| Increased expression of dopamine receptors on lymphocytes in Parkinson's disease | Q48107701 | ||
| Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis | Q48151704 | ||
| Active induction of experimental allergic encephalomyelitis | Q48175463 | ||
| Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model | Q48295121 | ||
| Profiling and identification of cerebrospinal fluid proteins in a rat EAE model of multiple sclerosis. | Q48667492 | ||
| Cell death and birth in multiple sclerosis brain | Q48680286 | ||
| Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease. | Q50855241 | ||
| Upregulation of alpha-synuclein in neurons and glia in inflammatory demyelinating disease. | Q53634898 | ||
| Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis | Q64865584 | ||
| P433 | issue | 2 | |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| P304 | page(s) | 1033-1045 | |
| P577 | publication date | 2016-01-22 | |
| P1433 | published in | Molecular Neurobiology | Q15716645 |
| P1476 | title | Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice | |
| P478 | volume | 54 |
| Q38381010 | Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial |
| Q88768074 | Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3 |
| Q90220043 | Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions |
| Q33884949 | Fluvoxamine stimulates oligodendrogenesis of cultured neural stem cells and attenuates inflammation and demyelination in an animal model of multiple sclerosis |
| Q42658376 | Implications of white matter damage in amyotrophic lateral sclerosis (Review). |
| Q47830428 | Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection. |
| Q90045593 | Isosibiricin inhibits microglial activation by targeting the dopamine D1/D2 receptor-dependent NLRP3/caspase-1 inflammasome pathway |
| Q99614380 | Lower CSF Homovanillic Acid Relates to Higher Burden of Neuroinflammation and Depression in People with HIV Disease |
| Q90558252 | Neuroprotection Induced by Dexpramipexole Delays Disease Progression in a Mouse Model of Progressive Multiple Sclerosis |
| Q47556460 | Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation |
| Q47133496 | Pramipexole in Treatment Resistant-Depression, Possible Role of Inflammatory Cytokines |
| Q58764700 | Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases |
| Q52649972 | The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease. |
| Q58755485 | α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes |
Search more.